Product Number |
ARP43311_T100 |
Product Page |
www.avivasysbio.com/rnf128-antibody-c-terminal-region-arp43311-t100.html |
Name |
RNF128 Antibody - C-terminal region (ARP43311_T100) |
Protein Size (# AA) |
428 amino acids |
Molecular Weight |
47 kDa |
NCBI Gene Id |
79589 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
1.0 mg/ml |
Gene Full Name |
Ring finger protein 128, E3 ubiquitin protein ligase |
Alias Symbols |
GRAIL |
Peptide Sequence |
Synthetic peptide located within the following region: LEEHVQSTNESLQLVNHEANSVAVDVIPHVDNPTFEEDETPNQETAVREI |
Product Format |
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
Reference |
Soares,L., (2004) Nat. Immunol. 5 (1), 45-54 |
Description of Target |
RNF128 is a type I transmembrane protein that localizes to the endocytic pathway. This protein contains a RING zinc-finger motif and has been shown to possess E3 ubiquitin ligase activity. Expression of RNF128 in retrovirally transduced T cell hybridoma significantly inhibits activation-induced IL2 and IL4 cytokine production. Induced expression of RNF128 was observed in anergic CD4(+) T cells, which suggested a role in the induction of anergic phenotype.The protein encoded by this gene is a type I transmembrane protein that localizes to the endocytic pathway. This protein contains a RING zinc-finger motif and has been shown to possess E3 ubiquitin ligase activity. Expression of this gene in retrovirally transduced T cell hybridoma significantly inhibits activation-induced IL2 and IL4 cytokine production. Induced expression of this gene was observed in anergic CD4(+) T cells, which suggested a role in the induction of anergic phenotype. Alternatively spliced transcript variants encoding distinct isoforms have been reported. |
Protein Interactions |
CEP76; APPBP2; TP53; UBE2H; UBE2E1; UBE2D1; Arhgdia; Arhgdib; RNF128; UBE2T; UBE2I; UBE2N; CD40LG; OTUB1; USP8; |
Reconstitution and Storage |
For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles. |
Enhanced Validation |
Relative Expression (Western Blot) |
|
|
Datasheets/Manuals |
Printable datasheet for anti-RNF128 (ARP43311_T100) antibody |
Blocking Peptide |
For anti-RNF128 (ARP43311_T100) antibody is Catalog # AAP43311 (Previous Catalog # AAPP11386) |
Immunogen |
The immunogen is a synthetic peptide directed towards the C terminal region of human RNF128 |
Uniprot ID |
Q8TEB7 |
Protein Name |
E3 ubiquitin-protein ligase RNF128 |
Sample Type Confirmation |
RNF128 is supported by BioGPS gene expression data to be expressed in HepG2 |
Protein Accession # |
NP_919445 |
Purification |
Protein A purified |
Nucleotide Accession # |
NM_194463 |
Tested Species Reactivity |
Human, Mouse |
Gene Symbol |
RNF128 |
Predicted Species Reactivity |
Human, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit |
Application |
WB |
Predicted Homology Based on Immunogen Sequence |
Cow: 86%; Dog: 93%; Guinea Pig: 100%; Horse: 93%; Human: 100%; Mouse: 93%; Rabbit: 93%; Rat: 93% |
Image 1 | Mouse CD4 T
| Lanes: 1: CD4 T cell lysate from WT mice, 2: CD4 T cell lysate from WT mice treated with anti-CD3/CD28, 3: CD4 T cell lysate from WT mice treated with FK506, 4: CD4 T cell lysate from WT mice treated with anti-CD3/CD28 and FK506, 5: CD4 T cell lysate from TRPV1 KO mice, 6: CD4 T cell lysate from TRPV1 KO mice treated with anti-CD3/CD28, 7: CD4 T cell lysate from TRPV1 KO mice treated with FK506, 8: CD4 T cell lysate from TRPV1 KO mice treated with anti-CD3/CD28 and FK506. Primary Antibody Dilution: 1:1000 Secondary Antibody: Anti-rabbit HRP Secondary Antibody Dilution: 1:10,000 Gene Name: RNF128 Submitted by: Christine Quinley, UCSD
|
|
Image 2 | Human HepG2
| WB Suggested Anti-RNF128 Antibody Titration: 1.25ug/ml Positive Control: HepG2 cell lysateRNF128 is supported by BioGPS gene expression data to be expressed in HepG2 |
|
Image 3 |
| 25 ug of the indicated Human whole cell or tissue extracts was loaded onto a 12% SDS-PAGE gel. 1 ug/mL of the antibody was used in this experiment. |
|